Walgreens Boots Alliance, Inc. $WBA Shares Sold by BI Asset Management Fondsmaeglerselskab A S

Key Points

• BI Asset Management Fondsmaeglerselskab A S sold 82,035 shares of Walgreens Boots Alliance, reducing its holdings by 80.9% to 19,380 shares, valued at $216,000.
• Several hedge funds, including Curat Global LLC and Sentry Investment Management LLC, also initiated new positions in Walgreens Boots Alliance during the same quarter.
• Walgreens Boots Alliance reported a 7.2% year-over-year revenue increase with an EPS of $0.38, surpassing estimates and reflecting a negative net margin of 4.07%.

BI Asset Management Fondsmaeglerselskab A S lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 80.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,380 shares of the pharmacy operator's stock after selling 82,035 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Walgreens Boots Alliance were worth $216,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Mariner LLC lifted its position in shares of Walgreens Boots Alliance by 21.4% during the fourth quarter. Mariner LLC now owns 149,240 shares of the pharmacy operator's stock worth $1,392,000 after purchasing an additional 26,325 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $198,000. First Trust Advisors LP acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $368,000. Dimensional Fund Advisors LP raised its holdings in Walgreens Boots Alliance by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,823,924 shares of the pharmacy operator's stock valued at $17,016,000 after acquiring an additional 272,895 shares in the last quarter. Finally, MetLife Investment Management LLC raised its holdings in Walgreens Boots Alliance by 1.9% in the fourth quarter. MetLife Investment Management LLC now owns 189,908 shares of the pharmacy operator's stock valued at $1,772,000 after acquiring an additional 3,610 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA remained flat at $11.98 on Friday. The firm has a market cap of $10.37 billion, a price-to-earnings ratio of -1.64, a P/E/G ratio of 1.41 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $13.25. The company has a fifty day simple moving average of $11.68 and a two-hundred day simple moving average of $11.23. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.34 by $0.04. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The company had revenue of $38.99 billion for the quarter, compared to analysts' expectations of $36.72 billion. During the same period in the prior year, the company earned $0.63 earnings per share. The firm's revenue was up 7.2% compared to the same quarter last year. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. UBS Group reaffirmed a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen assumed coverage on shares of Walgreens Boots Alliance in a report on Wednesday, May 21st. They issued a "hold" rating on the stock. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Two investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Reduce" and a consensus target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.